These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33652272)

  • 21. Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting.
    Brandao AP; Pinhata JMW; Simonsen V; Oliveira RS; Ghisi KT; Rabello MCS; Fukasava S; Ferrazoli L
    Tuberculosis (Edinb); 2020 Dec; 125():102004. PubMed ID: 33017720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting Mycobacterium tuberculosis complex and rifampicin resistance via a new rapid multienzyme isothermal point mutation assay.
    Lu Y; Li MC; Liu HC; Lin SQ; Zhao XQ; Liu ZG; Zhao LL; Wan KL
    Anal Biochem; 2021 Oct; 630():114341. PubMed ID: 34411551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains inhibiting wild type probe hybridization in the MTBDR plus assay by DNA sequencing directly from clinical specimens.
    Sinha P; Srivastava GN; Tripathi R; Mishra MN; Anupurba S
    BMC Microbiol; 2020 Sep; 20(1):284. PubMed ID: 32938393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Diagn Microbiol Infect Dis; 2015 May; 82(1):49-53. PubMed ID: 25749461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of missing probes in rifampicin resistant TB by Xpert MTB/RIF assay at a tertiary care centre in Mumbai.
    Kanade S; Nataraj G; Mehta P; Shah D
    Indian J Tuberc; 2019 Jan; 66(1):139-143. PubMed ID: 30797272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
    Singhal R; Arora J; Sah GC; Bhalla M; Sarin R; Prasad Myneedu V
    J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
    Click ES; Kurbatova EV; Alexander H; Dalton TL; Chen MP; Posey JE; Ershova J; Cegielski JP
    J Infect Dis; 2020 Jun; 221(12):2072-2082. PubMed ID: 32002554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of rifampicin resistance of Mycobacterium tuberculosis using multiplex allele specific polymerase chain reaction (MAS-PCR) in Pakistan.
    Ullah I; Ahmad W; Shah AA; Shahzada A; Tahir Z; Qazi O; Hasan F; Ayub N; Badar M; Butt ZA; Basit S
    Infect Genet Evol; 2019 Jul; 71():42-46. PubMed ID: 30890494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
    Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
    Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
    Tun T; Nyunt WW; Latt KZ; Samaranayaka A; Crump JA; Thinn KK; Cook GM; Aung HL
    Int J Mycobacteriol; 2016 Sep; 5(3):366-367. PubMed ID: 27847028
    [No Abstract]   [Full Text] [Related]  

  • 37. High positive predictive value of Xpert in a low rifampicin resistance prevalence setting.
    Trajman A; Durovni B; Saraceni V; Cordeiro-Santos M; Cobelens F; van den Hof S
    Eur Respir J; 2014 Dec; 44(6):1711-3. PubMed ID: 25186257
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xpert® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin.
    Vergara Gómez A; González-Martín J; García-Basteiro AL
    Med Clin (Barc); 2017 Nov; 149(9):399-405. PubMed ID: 28739268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.